Clinical Trial Update: Neoadjuvant Exisulind in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage II or Stage III Prostate Cancer [Phase 2]

View source ↗

Summary

This clinical trial update reports completion of a Phase 2 neoadjuvant study of Exisulind in men with Stage II or III prostate cancer undergoing radical prostat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Exisulind (exisulind)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED